ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The adenosine deaminase acting on RNA (ADAR) enzymes are essential for neuronal function and innate immune control. ADAR1 RNA editing prevents aberrant activation of antiviral dsRNA sensors through editing of long, double-stranded RNAs (dsRNAs). In this review, we focus on the ADAR2 proteins involved in the efficient, highly site-specific RNA editing to recode open reading frames first discovered in the GRIA2 transcript encoding the key GLUA2 subunit of AMPA receptors; ADAR1 proteins also edit many of these sites. We summarize the history of ADAR2 protein research and give an up-to-date review of ADAR2 structural studies, human ADARBI(ADAR2) mutants causing severe infant seizures, and mouse disease models. Structural studies on ADARs and their RNA substrates facilitate current efforts to develop ADAR RNA editing gene therapy to edit disease-causing single nucleotide polymorphisms (SNPs). Artificial ADAR guide RNAs are being developed to retarget ADAR RNA editing to new target transcripts in order to correct SNP mutations in them at the RNA level. Site-specific RNA editing has been expanded to recode hundreds of sites in CNS transcripts in Drosophila and cephalopods. In Drosophila and C. elegans, ADAR RNA editing also suppresses responses to self dsRNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second catalytically active enzyme, ADAR2, is less ubiquitously expressed, being enriched in neural and vascular tissues, and is mainly localized in the nucleus (for review [10]).”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A-to-I editing of coding and non-coding RNAs by ADARs
Nishikura, K. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.4 · Cited by 1,041
Regulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010 · cited 3×
“Another important neuronal transcript that undergoes editing by both ADAR1 and ADAR2 in a site-specific manner at five sites, resulting in the recoding of three codons, is the serotonin receptor subtype 2C (5-HT2C) receptor (Burns et al. 1997).”
BackgroundHiguchi, M., Maas, S., Single, F. N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., & Seeburg, P. H. (2000) · Nature · doi:10.1038/35017558 · Cited by 967
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923 · cited 1×
“Similar to mutations found in ADAR (Rice et al. 2012), most occurred in the deaminase domain, six were missense SNPs, while one was a small deletion at an exon–intron boundary.”
Self-citationControl of Kinetic Properties of AMPA Receptor Channels by Nuclear RNA Editing
Lomeli, H., Mosbacher, J., Melcher, T., Höger, T., Geiger, J. R. P., Kuner, T., Monyer, H., Higuchi, M., Bach, A., & Seeburg, P. H. (1994) · Science · doi:10.1126/science.7992055 · Cited by 746 · cited 5×
“RNA editing at this site can affect splicing of twomutually exclusive downstream exons, resulting in the generation of alternative flip and flop isoforms of GluA2–4, which in turn affect the gating, desensitization, and resensitization kinetics of the AMPARs (Lomeli et al. 1994; Koike et al. 2000; Krampfl et al. 2002;…”
BackgroundInfluentialLoss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Ishizuka, J. J., Manguso, R. T., Cheruiyot, C. K., Bi, K., Panda, A., Iracheta-Vellve, A., Miller, B. C., Du, P. P., Yates, K. B., Dubrot, J., et al. (2019) · Nature · doi:10.1038/s41586-018-0768-9 · Cited by 697
Nervous System Targets of RNA Editing Identified by Comparative Genomics
Hoopengardner, B., Bhalla, T., Staber, C., & Reenan, R. (2003) · Science · doi:10.1126/science.1086763 · Cited by 376 · cited 1×
“When new methods such as comparative genomics were applied, the number of known recoding events increased (Hoopengardner et al. 2003; Levanon et al. 2005).”
MethodAkbarian, S., Smith, M. A., & Jones, E. G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00922-d · Cited by 183
Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease
Khermesh, K., D'Erchia, A. M., Barak, M., Annese, A., Wachtel, C., Levanon, E. Y., Picardi, E., & Eisenberg, E. (2016) · RNA · doi:10.1261/rna.054627.115 · Cited by 160 · cited 2×
“One focus has been on patients with neurological and psychiatric disorders to determine if they have aberrant A-to-I editing (Akbarian et al. 1995; Iwamoto and Kato 2003; Gaisler-Salomon et al. 2014; Khermesh et al. 2016; Kitaura et al. 2017; Tran et al. 2019).”
BackgroundKawahara, Y., Grimberg, A., Teegarden, S., Mombereau, C., Liu, S., Bale, T. L., Blendy, J. A., & Nishikura, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3896-08.2008 · Cited by 105
Research works printed but not linked: 153
- 10.1007/s00401-010-0678-x · DOI
- 10.1016/j.jocn.2015.12.039 · DOI
- 10.1038/srep28649 · DOI · Paper page
- 10.1179/2047773214Y.0000000159 · doi:10.1179/2047773214y.0000000159
- 10.1016/j.tig.2022.03.013 · DOI
- 10.1093/nar/gkq764 · DOI
- 10.1371/journal.ppat.1010250 · DOI
- 10.1016/0092-8674(87)90239-X · DOI · Paper page
- 10.1016/0092-8674(88)90253-X · DOI · Paper page
- 10.1096/fj.201800490RR · DOI
- 10.1101/gr.164749.113 · DOI · Paper page
- 10.1016/j.celrep.2013.09.006 · DOI
- 10.1242/jcs.200055 · DOI · Paper page
- 10.1046/j.1471-4159.1994.62052057.x · DOI · Paper page
- 10.1046/j.1460-9568.1999.00479.x · DOI · Paper page
- 10.1038/nsmb825 · DOI · Paper page
- 10.1038/nn.2950 · DOI · Paper page
- 10.1126/science.270.5242.1677 · DOI · Paper page
- 2020, Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion, EMBO Rep, 21, e48467, 10.15252/embr.201948467 · DOI
- 10.1016/0006-3002(59)90644-4 · DOI · Paper page
- 10.1038/167483a0 · DOI · Paper page
- 10.1074/jbc.M110.130096 · DOI
- 10.1038/s41467-020-15435-1 · DOI
- 10.1242/jcs.00371 · DOI · Paper page
- 10.1371/journal.pgen.1006648 · DOI
- 10.1073/pnas.90.2.755 · DOI · Paper page
- 10.1038/s41576-018-0006-1 · DOI · Paper page
- 10.1080/10409238.2020.1856768 · DOI
- 10.1038/4561 · DOI · Paper page
- 10.1128/MCB.26.2.480-488.2006 · DOI · Paper page
- 10.1080/15476286.2017.1338232 · DOI
- 10.3390/genes9020079 · doi:10.3390/genes9020079
- 10.7717/peerj.4466 · DOI
- 10.1016/j.celrep.2020.107656 · DOI · Paper page
- 10.1016/j.neurobiolaging.2014.02.018 · DOI
- 10.1093/emboj/cdg327 · DOI
- 10.1074/jbc.M604484200 · DOI
- 1997, Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette, RNA, 3, 453
- 10.1038/nature09715 · DOI · Paper page
- 10.1016/S0896-6273(02)00693-1 · DOI · Paper page
- 10.1016/S0896-6273(03)00668-8 · DOI · Paper page
- 10.1186/s12862-015-0279-3 · DOI
- 10.1046/j.1460-9568.2003.02531.x · DOI · Paper page
- 10.1523/JNEUROSCI.22-24-10529.2002 · DOI · Paper page
- 10.1098/rsob.200085 · DOI
- 10.1073/pnas.93.5.1875 · DOI · Paper page
- 10.1523/JNEUROSCI.2021-10.2010 · DOI · Paper page
- 10.1016/j.nbd.2011.12.033 · DOI · Paper page
- 10.1016/0092-8674(93)90622-W · DOI · Paper page
- 2015, Regulation of ion channel and transporter function through RNA editing, Curr Issues Mol Biol, 17, 23
- 10.1074/jbc.M110.200881 · DOI
- 10.1016/S0021-9258(17)36972-7 · doi:10.1016/s0021-9258(17)36972-7
- 10.1016/j.neuron.2011.11.022 · DOI
- 10.1016/S0304-3940(03)00608-6 · DOI
- 10.4161/rna.6.3.8370 · DOI · Paper page
- 10.15252/embj.201694813 · DOI
- 10.1074/jbc.M110.186817 · DOI
- 10.1016/S0896-6273(00)80225-1 · DOI · Paper page
- 10.1002/iub.207 · DOI · Paper page
- 10.1021/ja01688a030 · DOI · Paper page
- 10.1073/pnas.95.23.13777 · DOI · Paper page
- 10.1038/s41587-021-01171-4 · DOI · Paper page
- 10.1038/427801a · DOI · Paper page
- 10.1038/sj.emboj.7600691 · DOI
- 10.1093/nar/gkr423 · DOI
- 10.1038/nature13682 · DOI · Paper page
- 10.1186/s12915-020-0747-0 · DOI
- 10.1016/S0021-9258(17)36857-6 · DOI
- 10.1073/pnas.91.24.11457 · DOI · Paper page
- 10.1111/epi.13700 · DOI
- 10.1016/S1097-2765(02)00649-4 · DOI
- 10.1016/0896-6273(93)90336-P · DOI · Paper page
- 10.1523/JNEUROSCI.20-06-02166.2000 · DOI · Paper page
- 10.1186/s13041-020-0545-1 · DOI
- 10.1046/j.0953-816x.2001.01841.x · DOI · Paper page
- 10.1128/MCB.17.5.2413 · DOI · Paper page
- 10.1523/JNEUROSCI.21-13-04572.2001 · DOI
- 10.1093/nar/gki239 · DOI · Paper page
- 10.1093/nar/gkt909 · DOI · Paper page
- 10.1126/science.aac7049 · DOI · Paper page
- 10.1093/nar/gkp599 · DOI · Paper page
- 10.1371/journal.pone.0004225 · DOI
- 10.1074/jbc.271.21.12221 · DOI · Paper page
- 10.1261/rna.7920904 · DOI
- 10.1126/science.1113150 · DOI · Paper page
- 10.1016/j.mcn.2012.10.009 · DOI
- 10.1016/j.celrep.2014.10.041 · DOI · Paper page
- 10.1038/emboj.2011.303 · DOI · Paper page
- 10.1074/jbc.M308742200 · DOI · Paper page
- 10.1136/jmedgenet-2020-107048 · DOI
- 10.1038/nsmb.3203 · DOI · Paper page
- 10.1074/jbc.271.50.31795 · DOI · Paper page
- 10.1038/379460a0 · DOI · Paper page
- 10.1016/j.celrep.2016.10.073 · DOI
- 10.1016/j.ymeth.2018.11.016 · DOI
- 10.1007/s00401-019-01999-w · DOI
- 10.1074/jbc.274.14.9472 · DOI · Paper page
- 10.1073/pnas.91.22.10596 · DOI
- 10.1128/MCB.15.3.1389 · DOI · Paper page
- 10.1074/jbc.272.1.473 · DOI
- 10.1261/rna.349107 · DOI · Paper page
- 10.1017/S1355838200000248 · DOI · Paper page
- 10.1016/S0092-8674(00)00049-0 · DOI · Paper page
- 10.1128/MCB.15.10.5376 · DOI · Paper page
- 10.1016/j.neuron.2006.01.025 · DOI · Paper page
- 10.1038/srep14941 · DOI · Paper page
- 10.1186/gb-2014-15-1-r5 · DOI · Paper page
- 10.1093/gbe/evaa046 · DOI
- 10.1038/s41467-019-09543-w · DOI
- 10.1074/jbc.M106745200 · DOI · Paper page
- 10.4161/rna.7.2.11286 · DOI
- 10.1016/j.tibs.2021.02.002 · DOI · Paper page
- 10.1093/nar/gky800 · DOI
- 10.1038/nmeth.2330 · DOI · Paper page
- 10.1038/s41587-021-01105-0 · DOI
- 10.1016/0092-8674(87)90238-8 · DOI · Paper page
- 10.1038/nature03364 · DOI
- 10.1038/ncomms10512 · DOI · Paper page
- 10.1038/19992 · DOI · Paper page
- 10.1523/JNEUROSCI.0443-08.2008 · DOI · Paper page
- 10.1038/s41467-019-10910-w · DOI · Paper page
- 10.1523/JNEUROSCI.23-28-09367.2003 · DOI · Paper page
- 10.1073/pnas.2336131100 · DOI · Paper page
- 10.1186/gb-2012-13-12-252 · DOI · Paper page
- 10.1038/ncomms1789 · DOI
- 10.1038/ncomms3745 · DOI · Paper page
- 10.1016/j.celrep.2018.03.118 · DOI
- 10.1016/S0378-1119(02)01016-8 · DOI
- 10.1016/0092-8674(91)90568-J · DOI · Paper page
- 10.1002/wrna.1665 · DOI · Paper page
- 10.1016/j.cell.2010.09.026 · DOI · Paper page
- 10.1074/jbc.M113.545731 · DOI
- 10.1038/nature24041 · DOI · Paper page
- 10.1016/j.ajhg.2020.02.015 · DOI
- 10.1093/nar/gks1353 · DOI
- 10.1038/ng.3731 · DOI
- 10.1093/nar/gkaa532 · DOI
- 10.1126/science.1091340 · DOI · Paper page
- 10.1038/s41593-018-0287-x · DOI · Paper page
- 10.1002/bies.201400055 · DOI
- 10.1016/S0896-6273(01)00192-1 · DOI
- 10.1083/jcb.200411129 · DOI · Paper page
- 10.1093/nar/gkw799 · DOI
- 10.1021/acs.biochem.7b01100 · DOI · Paper page
- 10.1038/nsmb.2129 · DOI · Paper page
- 10.1038/166237b0 · DOI · Paper page
- 10.1016/j.neures.2018.06.004 · DOI
- 10.1038/ncomms2303 · DOI · Paper page
- 10.1371/journal.pone.0048611 · DOI
- 10.1038/s41587-021-01180-3 · DOI · Paper page
- 10.1074/jbc.M106299200 · DOI
- 10.1186/s12864-017-4409-8 · DOI
- 10.21037/atm.2019.11.06 · DOI
Cited by
ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability
Vukić, D., Du, Q., Cherian, A., Amoruso, D., Brožinová, K., Wacheul, L., Lacovich, V., Zorbas, C., Yadav, L., Sedmík, J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag381
Self-citation
Metadata
- Authors
- Hajji, K., Sedmík, J., Cherian, A., Amoruso, D., Keegan, L. P., & O'Connell, M. A.
- Venue
- RNA
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2022-07-21
- Volume
- 28
- Issue
- 10
- Pages
- 1281-1297
- ISSN
- 1355-8382
- 1469-9001
- Cited by
- 31
- References
- 11
- Language
- en
- Funders
- Czech Science Foundation (GAČR 21-27329X, GAČR 20-11101S)
- European Union's Horizon 2020 research and innovation program under Marie Skłodowska-Curie grant (956810)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations. https://app.cochat.ai/papers/10.1261/rna.079266.122
- The paper
- Hajji, K., Sedmík, J., Cherian, A., Amoruso, D., Keegan, L. P., & O'Connell, M. A. (2022). ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations. RNA. https://doi.org/10.1261/rna.079266.122
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.